- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 253/06 - 1,2,4-Triazines
Patent holdings for IPC class C07D 253/06
Total number of patents in this class: 126
10-year publication summary
|
12
|
14
|
12
|
12
|
4
|
4
|
7
|
2
|
4
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer AG | 3522 |
7 |
| Shionogi & Co., Ltd. | 883 |
7 |
| The Broad Institute, Inc. | 1986 |
5 |
| Mitsubishi Tanabe Pharma Corporation | 398 |
5 |
| Bayer Cropscience AG | 1836 |
4 |
| Takeda Pharmaceutical Company Limited | 2700 |
4 |
| Nippon Soda Co., Ltd. | 885 |
4 |
| Promega Corporation | 588 |
4 |
| University of Greenwich | 69 |
4 |
| Tanabe Pharma Corporation | 147 |
4 |
| Mineralys Therapeutics, Inc. | 30 |
3 |
| Hoffmann-La Roche Inc. | 3818 |
2 |
| BASF SE | 21306 |
2 |
| Merck Sharp & Dohme Corp. | 2183 |
2 |
| The Johns Hopkins University | 5913 |
2 |
| Afferent Pharmaceuticals, Inc. | 24 |
2 |
| Beijing Tide Pharmaceutical Co. Ltd. | 116 |
2 |
| Denali Therapeutics Inc. | 271 |
2 |
| Jiangsu Hengrui Medicine Co., Ltd. | 686 |
2 |
| Nankai University | 263 |
2 |
| Other owners | 57 |